The Utah Senate convened on February 17, 2022, to discuss significant amendments to the Medical Cannabis Act, focusing on two companion bills, SB 190 and SB 195. The meeting highlighted various policy changes aimed at refining the state's medical cannabis program, which is still in its early stages.
Senator Vickers led the discussion, emphasizing the need to address issues surrounding Delta 8, a synthetic cannabinoid that has raised safety concerns due to its hallucinogenic properties. The proposed amendments would classify Delta 8 under the medical cannabis program, aligning Utah's regulations with those of other states like Pennsylvania and Connecticut, which have already banned its use.
Key changes proposed in SB 190 include stricter identification requirements for cannabinoids in cannabis products, clarifications on the sale of industrial hemp products, and the establishment of partnerships with research universities for cannabis testing. The bill also aims to ensure that cannabis licenses are not treated as commodities during business sales, thereby maintaining regulatory oversight.
Senator Escamilla introduced SB 195, which focuses on improving access to medical cannabis for patients in hospice care and clarifying the roles of caregivers. This bill also addresses the concerns of first responders, allowing them to hold medical cannabis cards while ensuring they do not consume cannabis within 12 hours of their shifts.
Both bills aim to enhance the safety and accessibility of medical cannabis while addressing concerns about its use in schools. The legislation stipulates that students requiring medical cannabis can receive their medication on school grounds, provided it is administered by a parent or designated caregiver, with the principal's approval. This provision aims to prevent students from being removed from school premises for medication administration.
The Senate voted in favor of the amendments, with SB 190 receiving 24 votes in favor and 3 against. The discussions reflect a collaborative effort among lawmakers to create a robust medical cannabis program that prioritizes patient access while ensuring safety and compliance with state regulations. Further deliberations and potential amendments are expected as the bills progress through the legislative process.